Prothena earned a $50 million milestone from Novo Nordisk related to enrollment in the Phase 3 CLEOPATTRA trial evaluating coramitug for ATTR-CM ...
President Trump swept into office last year promising to replenish the US government's energy backstop. But efforts have faltered and left the president with more limited options as he tries to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results